Thermo Fisher reports Q3 adjusted EPS $5.69, consensus $5.63

Reports Q3 revenue $10.57B, consensus $10.61B. “While market conditions further weakened during the third quarter, I’m very pleased with our team’s execution which enabled our company to deliver both excellent margin expansion and adjusted EPS growth,” said Marc Casper, chairman, president and CEO of Thermo Fisher Scientific. “Our experienced management team is leveraging our PPI Business System to effectively manage through the current dynamic environment. We also continue to invest for the future and a great example of this is our recently announced agreement to acquire Olink.” Casper added, “We are incredibly focused on delivering differentiated short-term performance while enhancing our long-term competitive position.”